(Q35950375)

11 August 2017

Doxorubicin conjugated functionalizable carbon dots for nucleus targeted delivery and enhanced therapeutic efficacy (English)

1 reference

11 August 2017

1 reference

1 reference

Lei Yang

1

1 reference

11 August 2017

Zheran Wang

2

1 reference

11 August 2017

Ju Wang

3

1 reference

11 August 2017

Weihua Jiang

4

1 reference

11 August 2017

Xuewei Jiang

5

1 reference

11 August 2017

Zhaoshi Bai

6

1 reference

11 August 2017

Yunpeng He

7

1 reference

11 August 2017

Jianqi Jiang

8

1 reference

11 August 2017

Dongkai Wang

9

1 reference

11 August 2017

Li Yang

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

9 March 2016

1 reference

11 August 2017

1 reference

11 August 2017

8

1 reference

11 August 2017

12

1 reference

11 August 2017

6801-6809

1 reference

Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications

11 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Nanomedicine-mediated cancer stem cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Carbon dots—Emerging light emitters for bioimaging, cancer therapy and optoelectronics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Integrating oxaliplatin with highly luminescent carbon dots: an unprecedented theranostic agent for personalized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Carbon-dot-based two-photon visible nanocarriers for safe and highly efficient delivery of siRNA and DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Nanoparticle-conjugated aptamer targeting hnRNP A2/B1 can recognize multiple tumor cells and inhibit their proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

One pot synthesis of highly luminescent polyethylene glycol anchored carbon dots functionalized with a nuclear localization signal peptide for cell nucleus imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Carbon nanodots featuring efficient FRET for real-time monitoring of drug delivery and two-photon imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Antibody conjugates with morpholinodoxorubicin and acid cleavable linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Surface characterization of immunosensor conjugated with gold nanoparticles based on cyclic voltammetry and X-ray photoelectron spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Chemical structures of hydrazine-treated graphene oxide and generation of aromatic nitrogen doping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

New strategy of efficient inhibition of cancer cells by carborane carboxylic acid-CdTe nanocomposites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6NR00247A

21 January 2018

Identifiers

DOI

10.1039/C6NR00247A

1 reference

11 August 2017

1 reference